US Food and Drug Administration approves double dose naloxone nasal spray

On 30 April 2021, the Food and Drug Administration approved a new formulation of naloxone nasal spray that is twice as strong as previous versions. The new product will contain 8mg of naloxone and will sit alongside existing 2mg and 4mg products.

Source: https://www.fda.gov/news-events/press-announcements/fda-approves-higher-dosage-naloxone-nasal-spray-treat-opioid-overdose